Immunome (IMNM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $16.47, -5.34% vs the prior close of $17.40.
- Volume 1.30M shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IMNM slides 5.3% to $16.47, a 6-month low. Closed at $16.47, -5.34% vs the prior close of $17.40. Day range $16.41–$17.40, opened at $17.40.
IMNM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IMNM slides 5.3% to $16.47, a 6-month low
- Closed at $16.47, -5.34% vs the prior close of $17.40. Day range $16.41–$17.40, opened at $17.40.
- Volume was 1.30M shares, 1.0x its 50-day average of 1.27M.
- Price is -32.1% vs its 50-day average ($24.25) and -27.2% vs its 200-day average ($22.61).
- 52-week range $14.64–$30.06; today's close sits at 12% of that range, 45.2% below the 52-week high.
Oct 15, 2026 — IMNM rises 1.2% to $17.40
- Closed at $17.40, +1.16% vs the prior close of $17.20. Day range $17.08–$17.61, opened at $17.31.
- Volume was 1.62M shares, 1.3x its 50-day average of 1.26M.
- Price is -28.8% vs its 50-day average ($24.44) and -23.1% vs its 200-day average ($22.64).
- 52-week range $13.94–$30.06; today's close sits at 21% of that range, 42.1% below the 52-week high.
Oct 14, 2026 — IMNM dips 2.2% to $17.20, a 6-month low, 3 down days in a row
- Closed at $17.20, -2.16% vs the prior close of $17.58. Day range $17.13–$18.05, opened at $17.35.
- Volume was 1.15M shares, 0.9x its 50-day average of 1.28M.
- Price is -30.1% vs its 50-day average ($24.60) and -24.1% vs its 200-day average ($22.66).
- 52-week range $13.53–$30.06; today's close sits at 22% of that range, 42.8% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — IMNM slides 8.2% to $17.58, a 6-month low
- Closed at $17.58, -8.20% vs the prior close of $19.15. Day range $17.43–$19.16, opened at $19.06.
- Volume was 2.20M shares, 1.7x its 50-day average of 1.27M.
- Price is -29.0% vs its 50-day average ($24.76) and -22.5% vs its 200-day average ($22.68).
- 52-week range $13.53–$30.06; today's close sits at 24% of that range, 41.5% below the 52-week high.
Oct 12, 2026 — IMNM dips 2.0% to $19.15
- Closed at $19.15, -2.05% vs the prior close of $19.55. Day range $19.08–$19.73, opened at $19.42.
- Volume was 835.70K shares, 0.7x its 50-day average of 1.26M.
- Price is -23.0% vs its 50-day average ($24.87) and -15.6% vs its 200-day average ($22.70).
- 52-week range $13.49–$30.06; today's close sits at 34% of that range, 36.3% below the 52-week high.
Oct 9, 2026 — IMNM rises 1.2% to $19.55
- Closed at $19.55, +1.24% vs the prior close of $19.31. Day range $18.88–$19.72, opened at $19.05.
- Volume was 998.00K shares, 0.8x its 50-day average of 1.26M.
- Price is -21.6% vs its 50-day average ($24.94) and -13.9% vs its 200-day average ($22.72).
- 52-week range $13.49–$30.06; today's close sits at 37% of that range, 35.0% below the 52-week high.
Oct 8, 2026 — IMNM rises 1.1% to $19.31
- Closed at $19.31, +1.13% vs the prior close of $19.09. Day range $18.52–$19.35, opened at $18.88.
- Volume was 2.13M shares, 1.7x its 50-day average of 1.23M.
- Price is -22.8% vs its 50-day average ($25.01) and -15.0% vs its 200-day average ($22.73).
- 52-week range $13.49–$30.06; today's close sits at 35% of that range, 35.8% below the 52-week high.
Oct 7, 2026 — IMNM dips 1.1% to $19.09, a 3-month low
- Closed at $19.09, -1.11% vs the prior close of $19.31. Day range $18.94–$19.56, opened at $18.94.
- Volume was 1.16M shares, 0.9x its 50-day average of 1.22M.
- Price is -23.9% vs its 50-day average ($25.09) and -16.0% vs its 200-day average ($22.74).
- 52-week range $13.41–$30.06; today's close sits at 34% of that range, 36.5% below the 52-week high.
Oct 6, 2026 — IMNM slides 8.8% to $19.31, a 3-month low on 1.9x normal volume
- Closed at $19.31, -8.79% vs the prior close of $21.17. Day range $18.92–$21.43, opened at $21.35.
- Volume was 2.31M shares, 1.9x its 50-day average of 1.19M — unusually heavy trading.
- Price is -23.3% vs its 50-day average ($25.17) and -15.1% vs its 200-day average ($22.74).
- 52-week range $12.41–$30.06; today's close sits at 39% of that range, 35.8% below the 52-week high.
Oct 5, 2026 — IMNM rises 1.3% to $21.17
- Closed at $21.17, +1.29% vs the prior close of $20.90. Day range $20.67–$21.48, opened at $20.79.
- Volume was 1.22M shares, 1.0x its 50-day average of 1.18M.
- Price is -16.1% vs its 50-day average ($25.23) and -6.9% vs its 200-day average ($22.75).
- 52-week range $11.55–$30.06; today's close sits at 52% of that range, 29.6% below the 52-week high.
- SEC filings that day: 8-K.
Oct 2, 2026 — IMNM ends flat (+0.0%) to $20.90
- Closed at $20.90, +0.05% vs the prior close of $20.89. Day range $20.82–$21.46, opened at $21.33.
- Volume was 1.17M shares, 1.0x its 50-day average of 1.19M.
- Price is -17.2% vs its 50-day average ($25.26) and -8.2% vs its 200-day average ($22.76).
- 52-week range $11.25–$30.06; today's close sits at 51% of that range, 30.5% below the 52-week high.
IMNM latest news & SEC filings
Every SEC filing by or about IMNM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Higgins Jack sold 13,200 shares at $25.32 (≈$334.22K) on Sep 11, 2026
- Higgins Jack sold 13,200 shares at $25.32 (≈$334.22K) on Sep 11, 2026
- Higgins Jack sold 13,200 shares at $25.32 (≈$334.22K) on Sep 11, 2026
- Higgins Jack sold 13,200 shares at $25.32 (≈$334.22K) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Barchas Isaac sold 11,048 shares at $27.25 (≈$301.06K) on Aug 12, 2026
- Barchas Isaac sold 11,048 shares at $27.25 (≈$301.06K) on Aug 12, 2026
- Barchas Isaac sold 11,048 shares at $27.25 (≈$301.06K) on Aug 12, 2026
- Barchas Isaac sold 11,048 shares at $27.25 (≈$301.06K) on Aug 12, 2026
- Barchas Isaac sold 62,291 shares at $26.23 (≈$1.63M) on Aug 11, 2026
- Barchas Isaac sold 62,291 shares at $26.23 (≈$1.63M) on Aug 11, 2026
- …plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 12, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 11, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $4.01M) (-100.0% vs Jun 30, 2025)
- Net income: -$73.13M (prior year -$43.40M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.65 (prior year -$0.50) (loss widened vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Barchas Isaac sold 15,248 shares at $26.06 (≈$397.36K) on Aug 7, 2026
- Barchas Isaac sold 15,248 shares at $26.06 (≈$397.36K) on Aug 7, 2026
- Barchas Isaac sold 15,248 shares at $26.06 (≈$397.36K) on Aug 7, 2026
- Barchas Isaac sold 15,248 shares at $26.06 (≈$397.36K) on Aug 7, 2026
- Barchas Isaac sold 20,840 shares at $26.06 (≈$543.09K) on Aug 6, 2026
- Barchas Isaac sold 20,840 shares at $26.06 (≈$543.09K) on Aug 6, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Horn Kinney sold 90,616 shares at $25.09 (≈$2.27M) on Aug 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade IMNM
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 3, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.23% (largest 8.8%). That is a volatile stock.
- Liquidity: about 1.50M shares (≈$24.70M) trade per day on average.
- 52-week position: $16.47 vs a range of $14.64–$30.06 (12% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Jack Higgins sold 13,200 shares on Sep 11, 2026.
- Latest filings: 8-K Oct 5, 2026; 10-Q Aug 11, 2026; 8-K Aug 11, 2026.
- Share count: 113.58M shares outstanding (Aug 6, 2026), +30.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
IMNM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 17.40 | 17.40 | 16.41 | 16.47 | 1.30M |
| Oct 15, 2026 | 17.31 | 17.61 | 17.08 | 17.40 | 1.62M |
| Oct 14, 2026 | 17.35 | 18.05 | 17.13 | 17.20 | 1.15M |
| Oct 13, 2026 | 19.06 | 19.16 | 17.43 | 17.58 | 2.20M |
| Oct 12, 2026 | 19.42 | 19.73 | 19.08 | 19.15 | 835.70K |
| Oct 9, 2026 | 19.05 | 19.72 | 18.88 | 19.55 | 998.00K |
| Oct 8, 2026 | 18.88 | 19.35 | 18.52 | 19.31 | 2.13M |
| Oct 7, 2026 | 18.94 | 19.56 | 18.94 | 19.09 | 1.16M |
| Oct 6, 2026 | 21.35 | 21.43 | 18.92 | 19.31 | 2.31M |
| Oct 5, 2026 | 20.79 | 21.48 | 20.67 | 21.17 | 1.22M |
| Oct 2, 2026 | 21.33 | 21.46 | 20.82 | 20.90 | 1.17M |
| Oct 1, 2026 | 21.17 | 21.49 | 20.71 | 20.89 | 1.10M |
| Sep 30, 2026 | 22.15 | 22.56 | 21.51 | 21.51 | 1.31M |
| Sep 29, 2026 | 21.64 | 22.01 | 21.35 | 21.89 | 917.00K |
| Sep 28, 2026 | 21.24 | 21.81 | 20.84 | 21.68 | 945.20K |
| Sep 25, 2026 | 22.43 | 22.65 | 21.15 | 21.41 | 2.42M |
| Sep 24, 2026 | 24.24 | 24.34 | 22.20 | 22.34 | 2.70M |
| Sep 23, 2026 | 25.88 | 25.94 | 24.03 | 24.24 | 2.27M |
| Sep 22, 2026 | 25.17 | 25.81 | 25.08 | 25.75 | 1.06M |
| Sep 21, 2026 | 24.63 | 25.25 | 24.19 | 25.07 | 1.18M |
About Immunome
Immunome (IMNM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BOTHELL, WA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1472012.
IMNM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jean Jacques Bienaime | Director | Jun 12, 2026 |
| Isaac Barchas | Director | Aug 12, 2026 |
| James P Boylan | Director | Jun 12, 2026 |
| Carol Schafer | Director | Jun 12, 2026 |
| Clay B Siegall | President and CEO | Jul 27, 2026 |
| Sandra M Swain | Director | Jun 12, 2026 |
| Philip Wagenheim | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jack Higgins | Chief Scientific Officer | Sep 15, 2026 |
| Kinney Horn | CHIEF BUSINESS OFFICER | Aug 6, 2026 |
| Robert Lechleider | Chief Medical Officer | Jul 27, 2026 |
| Max Rosett | Chief Financial Officer | Jul 27, 2026 |
| Clay B Siegall | President and CEO | Jul 27, 2026 |
| Sandra G. Stoneman | CHIEF LEGAL OFFICER & GC | Jul 27, 2026 |
| Philip Tsai | Chief Technical Officer | Jul 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Jack Higgins | Sale | 13,200 | $25.32 |
| Sep 11, 2026 | Jack Higgins | Sale | 13,200 | $25.32 |
| Sep 11, 2026 | Jack Higgins | Sale | 13,200 | $25.32 |
| Sep 11, 2026 | Jack Higgins | Sale | 13,200 | $25.32 |
| Aug 12, 2026 | Isaac Barchas | Sale | 11,048 | $27.25 |
| Aug 12, 2026 | Isaac Barchas | Sale | 11,048 | $27.25 |
| Aug 12, 2026 | Isaac Barchas | Sale | 11,048 | $27.25 |
| Aug 12, 2026 | Isaac Barchas | Sale | 11,048 | $27.25 |
| Aug 11, 2026 | Isaac Barchas | Sale | 62,291 | $26.23 |
| Aug 11, 2026 | Isaac Barchas | Sale | 62,291 | $26.23 |
| Aug 11, 2026 | Isaac Barchas | Sale | 62,291 | $26.23 |
| Aug 11, 2026 | Isaac Barchas | Sale | 62,291 | $26.23 |
| Aug 10, 2026 | Isaac Barchas | Sale | 10,125 | $26.07 |
| Aug 10, 2026 | Isaac Barchas | Sale | 10,125 | $26.07 |
| Aug 10, 2026 | Isaac Barchas | Sale | 10,125 | $26.07 |
IMNM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $6.94M | $-212.39M | -2.43 | $-190.92M |
| Dec 31, 2024 | $9.04M | $-292.96M | -5.00 | $-110.79M |
| Dec 31, 2023 | $14.02M | $-106.81M | -5.38 | $-7.57M |
| Dec 31, 2022 | — | $-36.90M | -3.09 | $-28.69M |
| Dec 31, 2021 | — | $-24.71M | -2.14 | $-18.23M |
Latest balance sheet: total assets $565.38M, total liabilities $40.30M, cash $217.71M (as of Jun 30, 2026).
IMNM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $26.25 |
| May 12, 2026 | 8-K Item 2.02 (results) | $22.69 |
| Mar 3, 2026 | 8-K Item 2.02 (results) | $21.54 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $15.50 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $10.46 |
| May 12, 2025 | 8-K Item 2.02 (results) | $7.94 |
| Mar 19, 2025 | 8-K Item 2.02 (results) | $8.57 |
| Jan 29, 2025 | 8-K Item 2.02 (results) | $9.35 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $11.59 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IMNM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.